Transcription of The PRISMAFLEX System - econnect.baxter.com
{{id}} {{{paragraph}}}
The PRISMAFLEX SystemTherapeutic Plasma ExchangeMaking possible Therapies. Therapeutic Plasma Exchange on the PRISMAFLEX PRISMAFLEX Control Unit is intended for: continuous Renal replacement therapy (CRRT) for patients weighing 20 kilograms or more with acute renal failure and/or fluid overload. Therapeutic Plasma Exchange (TPE) therapy for patients weighing 20 kilograms or more with diseases where removal of plasma components is Solution for Multiple TherapiesThe PRISMAFLEX System can help you meet the demands of multiple therapies with a versatile platform that can be customized to specific patient Pressure (TMP) (mmHg)QB = 100 mL/min QF max = 42 mL/minQB = 200 mL/min QF max = 79 mL/minQB = 250 mL /min QF max = 97 mL/minPlasma Filtration Rate, QF (mL/min)Plasma Filtration Rate (QF) Capability with Increased Blood Flow Rate (QB)Typical mean values obtained from laboratory testing of post-sterilization sample lots.
One Platform. Multiple Therapies. Therapeutic Plasma Exchange on the PRISMAFLEX System. The PRISMAFLEX Control Unit is intended for: • Continuous Renal Replacement Therapy (CRRT) for patients weighing
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Argatroban for anticoagulation in continuous renal, Argatroban for anticoagulation in continuous renal replacement therapy, IV ANTI-INFECTIVE MEDICATION DOSING IN, Continuous Renal Replacement Therapy, RENAL REPLACEMENT THERAPY IN CRITICAL CARE, Dialysis, Renal, Potassium Replacement, Recommendations: Other Suppo rtive Therapy, Ceftriaxone, Cefazolin